CONSTELLA linaclotide 145 microgram hard capsule bottle

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

linaclotide, Quantity: 0.145 mg

Disponible des:

Abbvie Pty Ltd

formulario farmacéutico:

Capsule, hard

Composición:

Excipient Ingredients: microcrystalline cellulose; calcium chloride dihydrate; leucine; hypromellose; titanium dioxide; potable water; Gelatin; sodium lauryl sulfate; propylene glycol; butan-1-ol; ethanol; iron oxide yellow; strong ammonia solution; iron oxide black; methanol; Shellac; sulfuric acid

Vía de administración:

Oral

Unidades en paquete:

4, 30

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

CONSTELLA is indicated in adults for the treatment of: ? irritable bowel syndrome with constipation (IBS-C) and ? chronic idiopathic constipation (CIC) when dietary fibre, laxatives and stool softeners have not been sufficient and with adequate constipation minimisation dietary support.

Resumen del producto:

Visual Identification: White to off-white opaque body and cap, size '3' hard capsules with "FL 145" printed in grey ink on the cap.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 23 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Estat d'Autorització:

Registered

Data d'autorització:

2019-06-18